Comments

Bio-Rad Laboratories Stock Price, Quotes and Forecasts

Q: What sector and industry does Bio-Rad Laboratories (BIO) operate in?

Bio-Rad Laboratories is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NYSE.

BIONYSE

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$241.02

8.473.64%

At close: -

$241.02

0.000.00%

After Hours: 4:00 PM EDT

Q1 2025 Earnings were released on Thu May 1st, after the market close

The most recent conference call was at 17:30 PM, 7 days ago Click to view past webcast

Bio-Rad Laboratories (BIO) Forecast

News Earnings Bio-Rad Laboratories (BIO) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Bio-Rad Laboratories Stock Price, Quotes and Forecasts | NYSE:BIO | Benzinga

Explore Bio-Rad Laboratories stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for BIO.

Open	$233.09
Close	$241.02
Volume / Avg.	258.27K / 385.53K
Day Range	$233.09 - $243.75
52 Wk Range	215.38 - 387.99
Market Cap	$6.75B
P/E Ratio	-
Dividend Yield	-
Exchange	NYSE
RSI	49
Short Interest	6.5%
Days to Cover	2.39

Recent News

Stocks Head For Weekly Gains, US Treasury Yields Fall Below 4.5%: What's Driving Markets Friday?

Stocks are headed for weekly gains, with the Dow Jones dipping slightly and the S&P 500 and Nasdaq trading just above the flatline Friday.

Erica Kollmann

S&P 500 Shake-Up: New Entrants Driving Market Momentum

The S&P 500 is a widely recognized benchmark for the US stock market, and it has undergone reshuffling due to the quarterly rebalancing process. This shake-up, driven by shifts in company performance and market capitalization, provides a unique lens into the evolving dynamics of the business world. The inclusion of several companies reflects a changing market terrain.

MarketBeat

S&P 500 Shake-Up: New Entrants Driving Market Momentum

MarketBeat

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Dec 24

Jan

Feb

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.6

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$233.09
Close	$241.02
Volume / Avg.	258.27K / 385.53K
Day Range	$233.09 - $243.75
52 Wk Range	215.38 - 387.99
Market Cap	$6.75B
P/E Ratio	-
Dividend Yield	-
Exchange	NYSE
RSI	49
Short Interest	6.5%
Days to Cover	2.39

About Bio-Rad Laboratories Inc.

Sector

Health Care

Industry

Life Sciences Tools & Services

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells produ...

Got Questions? Ask

Analyze BIO's financials

What are analysts' targets for BIO?

What is BIO's debt-to-equity ratio?

What is BIO's dividend yield?

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy Bio-Rad Laboratories (BIO) stock?

You can purchase shares of Bio-Rad Laboratories (NYSE:BIO) through any online brokerage.

View our list of the best stock brokerages

Who are Bio-Rad Laboratories (BIO) competitors?

Other companies in Bio-Rad Laboratories’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), 10x Genomics (NASDAQ:TXG), BioLife Solutions (NASDAQ:BLFS) and Waters (NYSE:WAT).

What is the forecast, or price target, for Bio-Rad Laboratories (BIO) stock?

Bio-Rad Laboratories has a consensus price target of $387.43.

What is the current price for Bio-Rad Laboratories (BIO)?

The stock price for Bio-Rad Laboratories (NYSE: BIO) is $241.02 last updated May 8, 2025 at 7:00 PM EDT.

Does Bio-Rad Laboratories (BIO) pay a dividend?

A quarterly cash dividend of 0.00 per share of Class A Common Stock. The quarterly cash dividend was payable on Invalid DateTime to stockholders of record on Invalid DateTime.

When is Bio-Rad Laboratories (NYSE:BIO) reporting earnings?

Bio-Rad Laboratories’s Q2 earnings are confirmed for Thursday, July 31, 2025.

Is Bio-Rad Laboratories (BIO) going to split?

There is no upcoming split for Bio-Rad Laboratories.

What sector and industry does Bio-Rad Laboratories (BIO) operate in?

Bio-Rad Laboratories is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NYSE.